Su Zhen Insider Profile
4 Followers
Su Zhen, Director at CytomX Therapeutics, holds ― shares in CytomX Therapeutics (Ticker: CTMX), holds 15.51K shares in Karyopharm Therapeutics (Ticker: KPTI). Most recently, Su Zhen ― shares of CytomX Therapeutics on ― for an estimated value of ―.
Su Zhen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Su Zhen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Su Zhen
Su Zhen's Trading History
CytomX Therapeutics
―
Director
―
―
Karyopharm Therapeutics
May 26, 2026
Director
Uninformative Buy
―
$25.12K
List of latest transactions for each holding click on a transaction to see Su Zhen's performance on stock
You May Also Like
Su Zhen insider profile FAQ
What is the percentage of profitable transactions made by Su Zhen?
The percentage of profitable transactions made by Su Zhen is ―.
What is the average return per transaction made by Su Zhen?
The average return per transaction made by Su Zhen is ―.
What stocks does Su Zhen hold?
Su Zhen holds: CTMX, KPTI stocks.
What was Su Zhen’s latest transaction?
Su Zhen latest transaction was an Uninformative Buy of ―.
What was Su Zhen's most profitable transaction?
Su Zhen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Su Zhen's role in CytomX Therapeutics?
Su Zhen's role in CytomX Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.